List of works - James D Neaton

A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias

scientific article published on 10 July 2018

A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias

scientific article published on 8 November 2017

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

scientific article

A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa

scientific article

Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy

scientific article

Adult and paediatric haematology and clinical chemistry laboratory reference limits for Liberia

scientific article published on 25 November 2020

Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: A Feasibility Randomized Trial ⬇️

scientific article published on October 17, 2012

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study

scientific article published on 8 April 2014

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

scientific article

Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection

scientific article

Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study

scientific article

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

scientific article

HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction

scientific article

High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection

scientific article

Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death

scientific article

Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women

scientific article

Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients

scientific article

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.

scientific article published in November 2011

Inflammation, coagulation and cardiovascular disease in HIV-infected individuals

scientific article

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

scientific article

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

scientific article

Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy

scientific article

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis

scientific article

Issues in regulatory guidelines for data monitoring committees

scientific article published in January 2004

Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

scientific article

Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial

scientific article published on 24 October 2011

Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease

scientific article published in July 2014

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

scientific article

Morbidity and mortality according to latest CD4+ cell count among HIV positive individuals in South Africa who enrolled in project Phidisa

scientific article

N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients

scientific article

Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies

scientific article

Pilot study of vascular health in survivors of osteosarcoma

scientific article

Plasma levels of soluble CD14 independently predict mortality in HIV infection

scientific article

Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease

scientific article (publication date: 2012)

Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers

scientific article

Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy study

scientific article

Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health

scientific article

Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected individuals

scientific article

Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy

scientific article

Risk of cancers during interrupted antiretroviral therapy in the SMART study

scientific article

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

article by Faiez Zannad et al published 4 October 2018 in The New England Journal of Medicine

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation

scientific article

Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.

scientific article

Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010

scientific article

Strengthening biostatistics resources in sub-Saharan Africa: research collaborations through U.S. partnerships

scientific article

The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies

scientific article

The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms

scientific article

The prevention and treatment of missing data in clinical trials

scientific article

When to start antiretroviral therapy: the need for an evidence base during early HIV infection

scientific article

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

scientific article

List of works by James D Neaton

A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias

A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa

Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy

Adult and paediatric haematology and clinical chemistry laboratory reference limits for Liberia

Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: A Feasibility Randomized Trial ⬇️

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection

Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction

High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection

Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death

Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women

Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.

Inflammation, coagulation and cardiovascular disease in HIV-infected individuals

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis

Issues in regulatory guidelines for data monitoring committees

Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial

Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

Morbidity and mortality according to latest CD4+ cell count among HIV positive individuals in South Africa who enrolled in project Phidisa

N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients

Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies

Pilot study of vascular health in survivors of osteosarcoma

Plasma levels of soluble CD14 independently predict mortality in HIV infection

Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease

Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers

Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy study

Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health

Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected individuals

Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy

Risk of cancers during interrupted antiretroviral therapy in the SMART study

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation

Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.

Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010

Strengthening biostatistics resources in sub-Saharan Africa: research collaborations through U.S. partnerships

The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies

The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms

The prevention and treatment of missing data in clinical trials

When to start antiretroviral therapy: the need for an evidence base during early HIV infection

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial